Abstract
Piperacillin/tazobactam (PTZ) is frequently used in patients with diabetic foot infections. Herein, we report a patient who developed severe neutropenia, thrombocytopenia, and fever while receiving PTZ for a diabetic foot infection. We recommend vigilance when long-term PTZ use is planned in patients with diabetic foot infections.
MeSH terms
-
Aged
-
Anti-Bacterial Agents / adverse effects*
-
Anti-Bacterial Agents / therapeutic use
-
Diabetes Mellitus, Type 2 / blood*
-
Diabetes Mellitus, Type 2 / drug therapy
-
Diabetic Foot / blood*
-
Diabetic Foot / drug therapy
-
Diabetic Foot / surgery
-
Fever / blood
-
Fever / chemically induced*
-
Humans
-
Male
-
Neutropenia / chemically induced*
-
Penicillanic Acid / adverse effects
-
Penicillanic Acid / analogs & derivatives
-
Penicillanic Acid / therapeutic use
-
Piperacillin / adverse effects
-
Piperacillin / therapeutic use
-
Piperacillin, Tazobactam Drug Combination
-
Thrombocytopenia / chemically induced*
Substances
-
Anti-Bacterial Agents
-
Piperacillin, Tazobactam Drug Combination
-
Penicillanic Acid
-
Piperacillin